Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jeonghoon Sun"'
Autor:
Randy Hecht, Yue-Sheng Li, Jeonghoon Sun, Ed Belouski, Michael Hall, Todd Hager, Junming Yie, Wei Wang, Dwight Winters, Stephen Smith, Chris Spahr, Lei-Ting Tam, Zhongnan Shen, Shanaka Stanislaus, Narumol Chinookoswong, Yvonne Lau, Allen Sickmier, Mark Leo Michaels, Thomas Boone, Murielle M Véniant, Jing Xu
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e49345 (2012)
Fibroblast growth factor 21 (FGF21) is a promising drug candidate for the treatment of type 2 diabetes. However, the use of wild type native FGF21 is challenging due to several limitations. Among these are its short half-life, its susceptibility to i
Externí odkaz:
https://doaj.org/article/4b03784bd0594b29a2d0316fd49362ba
Autor:
Douglas D, Banks, Jon F, Cordia, Vladimir, Spasojevic, Jeonghoon, Sun, Sarah, Franc, Younhee, Cho
Publikováno v:
Protein science : a publication of the Protein Society. 27(12)
Inert co‐solutes, or excipients, are often included in protein biologic formulations to adjust the tonicity of liquid dosage forms intended for subcutaneous delivery. Despite the low concentration of their use, many of these excipients alter protei
Autor:
Marc W. Retter, Mark Leo Michaels, Derek E. Piper, Katherine C Matsuda, Lei Zhou, Chadwick T. King, Wei Wang, Higbee Jared Martin, Jeonghoon Sun, Howard Monique L, Simon Jackson, Ren Xu, Randal R. Ketchem, Brandon Ason, Jie Tang, Kirk Henne, Joyce Chi Yee Chan
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 353(1)
Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as an attractive therapeutic target for cardiovascular disease. Monoclonal antibodies (mAbs) that bind PCSK9 and prevent PCSK9:low-density lipoprotein receptor complex formation reduce
Autor:
Jeonghoon Sun, Tae Woo Kwon, Demetri Theodore Moustakas, Jang H. Han, Mi Young Seo, Hui-hua Lu, Jong Won Kim, Anang A. Shelat, Chon Saeng Kim
Publikováno v:
Journal of Virology. 77:571-582
Hepatitis C virus (HCV) is a positive-strand RNA virus that encodes a helicase required for viral replication. Although HCV does not replicate through a DNA intermediate, HCV helicase unwinds both RNA and DNA duplexes. An X-ray crystal structure of t
Publikováno v:
Journal of Molecular Biology. 307:1103-1112
We have determined the sequence requirements for the N-terminal protein hinge of the active-site lid of triosephosphate isomerase. The codons for the hinge (PVW) were replaced with a genetic library of all possible 8000 amino acid combinations. The m
Autor:
Nicole S. Sampson, Jeonghoon Sun
Publikováno v:
Biochemistry. 38:11474-11481
In previous work we tested what three amino acid sequences could serve as a protein hinge in triosephosphate isomerase [Sun, J., and Sampson, N. S. (1998) Protein Sci. 7, 1495-1505]. We generated a genetic library encoding all 8000 possible 3 amino a
Autor:
Nicole S. Sampson, Jeonghoon Sun
Publikováno v:
Protein Science. 7:1495-1505
We have determined the sequence requirements for a protein hinge in triosephosphate isomerase. The codons encoding the hinge at the C-terminus of the active-site lid of triosephosphate isomerase were replaced with a genetic library of all possible 8,
Publikováno v:
Biochemistry. 35:12788-12795
The proximal iron ligand in horseradish peroxidase (HRP) is His-170. The H170A mutant of polyhistidine-tagged HRP (hHRP) has been expressed in a baculovirus system and has been purified and characterized. At pH 7, the Soret maximum of the mutant is a
Autor:
Wei Wang, E. Allen Sickmier, Yvonne Y. Lau, Lei-Ting Tam, Jeonghoon Sun, Zhongnan Shen, Murielle M. Véniant, Randy Ira Hecht, Chris Spahr, Dwight Winters, Jing Xu, Ed Belouski, Michael Hall, Shanaka Stanislaus, Junming Yie, Mark Leo Michaels, Yue-Sheng Li, Narumol Chinookoswong, Stephen Smith, Todd Hager, Thomas C. Boone
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 11, p e49345 (2012)
PLoS ONE, Vol 7, Iss 11, p e49345 (2012)
Fibroblast growth factor 21 (FGF21) is a promising drug candidate for the treatment of type 2 diabetes. However, the use of wild type native FGF21 is challenging due to several limitations. Among these are its short half-life, its susceptibility to i
The Mechanism of Inhibition of Antibody-Based Inhibitors of Membrane-Type Serine Protease 1 (MT-SP1)
The mechanisms of inhibition of two novel scFv antibody inhibitors of the serine protease MT-SP1/matriptase reveal the basis of their potency and specificity. Kinetic experiments characterize the inhibitors as extremely potent inhibitors with K(I) va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0254ba8047c839f6ed175d9fd36c7a9d
https://europepmc.org/articles/PMC2041882/
https://europepmc.org/articles/PMC2041882/